> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# PharMEDium Recalls Compounded Drugs Due to Hospira Recall
- URL: https://www.fdaweb.com/pharmedium-recalls-compounded-drugs-due-to-hospira-recall/
- Published: 2017-06-28T12:00:00.000Z
- Updated: 2026-09-14T22:32:00.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139054

PharMEDium Services has recalled specific lots of potassium phosphate and succinylcholine chloride due to a lack of sterility assurance. The recall is related to a [6/15-announced](https://www.fda.gov/Safety/Recalls/ucm563383.htm?ref=fdaweb.com) Hospira recall because the PharMEDium products were compounded using certain Hospira products. The latest [recall notice](https://www.fda.gov/Safety/Recalls/ucm564845.htm?ref=fdaweb.com) says that in the event a non-sterile product is administered to a patient, adverse events ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis may occur.